Biotechnology Stocks II Performance Guide: Monte Rosa Therapeutics, Inc. (GLUE)
GLUE has no dividends.
Table and Chart of GLUE Performance
See what a $1,000 investment in GLUE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GLUE Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $24.52 |
| End Date | Jul-26-2024 |
| End Price | $4.67 |
| # Prices | 37 |
| Min Date | Nov-30-2023 |
| Min Price | $3.10 |
| Max Date | Aug-31-2021 |
| Max Price | $35.69 |
| Total Return | -80.95% |
| Annualized Return | -41.60% |
| Current Value of $1,000 Purchase | $190 |
| Number Returns | 666 |
| Average Return | -37.59% |
| Number Profitable Returns | 70 |
| Percent Profitable Returns | 10.51% |
| Number Unprofitable Returns | 596 |
| Percent Unprofitable Returns | 89.49% |
| Profitable to Unprofitable Returns Ratio | 0.12 |
| GLUE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $284,656,000 |
| Beta | 1.380 | Price to Sales | 251.73 |
| Earnings per Share | $-2.5100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.756 |
| PRICE DATA | |
| 52 Week High | $8.84 |
| 52 Week Low | $2.44 |
| Analyst Target Price | $16 |
| 50-Day Moving Average | $4.154 |
| 200-Day Moving Average | $4.914 |
| FINANCIAL DATA | |
| Revenue per Share | $0.02 |
| Revenue | $1,064,000 |
| Profit Margin | 0% |
| Return on Equity | -68.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GLUE Compare Returns with S&P 500
GLUE Trendline Chart
GLUE Moving Average Chart
GLUE Stock Return Map - See Patterns of Gains and Losses
GLUE Stock Returns/Purchase Dates